Genometrix, GE Medical Systems Combine Forces to Study Disease Risk | GenomeWeb

NEW YORK, April 23 – Genometrix and GE Medical Systems said Monday they have agreed to participate in a joint research project that would apply their respective genomic and imaging technologies to determine a patient’s risk for developing certain diseases. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.